Peptides for targeting the prostate specific membrane antigen
The invention provides isolated PSMA binding peptides, as well as pharmaceutical compositions thereof. Also provided are diagnostic and therapeutic methods utilizing the PSMA binding peptides, as well as methods for identifying further PSMA binding peptides.
1. A peptide compound which selectively binds to the extracellular portion of human PSMA and comprises the amino acid sequence QKHHNYL (SEQ ID NO:109).
2. The peptide of claim 1 , wherein the peptide consists of the amino acid sequence QKHHNYL (SEQ ID NO:109).
3. The peptide of claim 1 , wherein the peptide comprises a cysteine residue at the N and C terminus.
4. The peptide of claim 3 , wherein the peptide is cyclic.
5. A peptide which selectively binds to the extracellular portion of human PSMA, wherein the peptide comprises the amino acid sequence set forth as SEQ ID NO:1.
6. A peptide which selectively binds to the extracellular portion of human PSMA and comprises the amino acid sequence QKHHNYL (SEQ ID NO:109), and wherein the peptide is 9 amino acid residues in length.
7. The peptide of claim 5 or 1 , wherein the peptide is 9 amino acid residues in length.